A detailed history of Gerber, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gerber, LLC holds 342 shares of LLY stock, worth $269,560. This represents 0.22% of its overall portfolio holdings.

Number of Shares
342
Previous 342 -0.0%
Holding current value
$269,560
Previous $310 Million 2.15%
% of portfolio
0.22%
Previous 0.24%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $14,497 - $18,180
20 Added 6.21%
342 $310 Million
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $190,688 - $255,114
322 New
322 $251 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gerber, LLC Portfolio

Follow Gerber, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gerber, LLC with notifications on news.